AzTrials
AzTrials

Polycystic Ovary SyndromeNCT01859663

Comparison of Lifestyle Markers Between Women With and Without Polycystic Ovary Syndrome

An observational study of Polycystic Ovary Syndrome and Dietary Habits, run by Cornell University at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to identify lifestyle factors associated with PCOS and understand how diet and activity levels impact features of PCOS. The secondary aim is to examine psychosocial factors (e.g., health beliefs) of women with PCOS. Read more about this study

Who is it for?
Ages 18 to 48 years, women onlyHealthy volunteers can take part
How many people
126 participants
Where
3 sitesUnited States
Study dates
May 2013to May 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 48 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: New York State. Must be between 18-48 years, with a BMI of 18 kg/m2 or higher.

Who may be able to join

  • Between 18 and 48 years
  • BMI ≥ 18 kg/m2
  • If ≥ 21 years old, must have completed a pelvic exam in the past 2 years
  • In PCOS if: Confirmed PCOS diagnosis from their primary care provider

Who cannot join

  • Use of oral contraceptives, fertility medications, or any drugs known to influence reproductive function
  • Pregnant or breastfeeding

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Human Metabolic Research Unit, Cornell University

    Ithaca, New York, 14853

  • Strong Fertility Center

    Rochester, New York, 14623

  • CRC at University of Rochester Medical Center

    Rochester, New York, 14642

Other trials in United States

About this study

Official title: Baseline Assessment of Dietary Intake and Physical Activity in Women With Polycystic Ovary Syndrome (PCOS)

The purpose of the study is to identify lifestyle factors associated with PCOS and understand how diet and activity levels impact features of PCOS. The secondary aim is to examine psychosocial factors (e.g., health beliefs) of women with PCOS.

Read the detailed description

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects 6-12% of reproductive-aged women within the general population. Currently, there is limited knowledge on the current lifestyles of women with PCOS and the psychosocial factors associated with PCOS.

The researchers plan to examine potential lifestyle differences and psychosocial factors between PCOS and healthy women. The Research Team is also interested in the relationships between biological markers and lifestyle endpoints in women with and without PCOS. Previous literature has shown there are biological marker differences between those with and without PCOS. By examining these relationships, researchers may further understand whether PCOS status is associated with lifestyle parameters.

To accomplish these objectives, 360 women (120 women with PCOS, 120 women without PCOS and with normal menstrual cycles, and 120 women without PCOS and with irregular menstrual cycles) will be included in this study. An equal number of lean and overweight/obese women will be recruited within each group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2). Women will be included in the PCOS group if they have a confirmed PCOS diagnosis from their primary care provider. Participants will complete a food frequency questionnaire, a sleep questionnaire, and a physical activity questionnaire. A researcher may also provide participants with a waist-worn accelerometer to monitor physical activity and a wrist-worn accelerometer to monitor sleep for a week. Ultrasound scans of the ovaries will be assessed and the following metabolic parameters will be assessed: (1) 75-gram oral glucose tolerance test; (2) dual X-ray absorptiometry (DXA) scan; (3) vitals and anthropometry assessment to measure waist and hip circumference, height, weight, blood pressure, and heart rate; (4) fasting blood tests to detect androgens (i.e., total testosterone, androstenedione, free androgen index); and (5) an (optional) subcutaneous fat biopsy. Women with and without PCOS will also be asked to complete a questionnaire that will assess the psychosocial factors (e.g., health beliefs). This can be conducted online, in person, or through phone.

Keywords
Polycystic Ovary Syndrome (PCOS), Diet, Exercise, Questionnaires, Health Beliefs
Medical subject headings
Polycystic Ovary Syndrome, Feeding Behavior, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01859663
Study groupRoleWhat they receive
Women with a past diagnosis of PCOSWe aim to recruit 120 women with a past diagnosis of PCOS. An equal number of lean and overweight/obese women will be recruited within this group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2).
Women with a history of regular menstrual cyclesWe aim to recruit 120 women with a history of regular menstrual cycles. An equal number of lean and overweight/obese women will be recruited within this group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2).
Women with a history of irregular menstrual cyclesWe aim to recruit 120 women with a history of irregular menstrual cycles, and no previous diagnosis of PCOS. An equal number of lean and overweight/obese women will be recruited within this group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in diet between women with and without PCOS

    A food frequency questionnaire will be administered to assess diet composition for the last three months.

    Measured: 1 week

Secondary outcomes (16)
  1. Differences in exercise between women with and without PCOS

    An accelerometer will be administered to assess physical activity for 1 week.

    Measured: 1 week

  2. Differences in psychosocial factors (e.g., health beliefs) of women with and without PCOS

    A questionnaire will be administered to assess psychosocial factors of women with PCOS.

    Measured: 1-2 weeks

  3. Differences in sleep patterns between women with and without PCOS

    A wrist-worn accelerometer will be administered to assess sleep patterns for 6 consecutive nights.

    Measured: 6 consecutive nights

  4. LH-FSH ratio

    The ratio of circulating LH to FSH concentrations in the serum will be determined for each participant and compared across groups

    Measured: 1 day

  5. Hirsutism Score

    Degree of hirsutism as judged by the Ferriman-Gallwey scale will be determined and compared across groups

    Degree of hirsutism as judged by the Ferriman-Gallwey scale will be determined and compared across groups

    Measured: 1 day

  6. Androgen concentrations

    Total testosterone, androstenedione and free androgen index concentrations in serum will be determined and compared across groups.

    Measured: 1 day

  7. Menstrual Cycle Length

    Average menstrual cycle length as determined by self-reported history will be determined and compared across groups

    Measured: 1 day

  8. Body Mass Index

    The ratio of weight to height will be determined and compared across groups.

    Measured: 1 day

  9. Waist-to-Hip Ratio

    The ratio of waist circumference to hip circumference will be determined and compared across groups

    Measured: 1 day

  10. Ovarian Volume

    The size of each ovary will be determined using ultrasonography for each participant during study participation and compared between groups.

    Measured: 1 day

  11. Insulin Sensitivity

    Insulin sensitivity will be determined by administration of an oral glucose tolerance test and compared between groups.

    Measured: 1 day

  12. Serum progesterone concentration

    The serum progesterone concentration will be determined during study participation, assessed in association with luteal dynamics and compared between groups.

    Measured: 1 day

  13. Blood pressure

    Blood pressure will be determined and compared between groups.

    Measured: 1 day

  14. Serum markers of metabolic syndrome

    Lipids, glucose and HbA1C concentrations will be determined and compared between groups.

    Measured: 1 day

  15. Body fat distribution

    Percentage and distribution of fat and lean mass as assessed using DXA technology will be compared between groups.

    Measured: 1 day

  16. Subcutaneous fat biopsy (optional)

    Subcutaneous fat cells, which represent important sites of reproductive hormone synthesis, will be assessed and compared across groups

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2013 (estimated)
  2. Study startMay 2013
  3. Primary completionMay 2022
  4. Study completionMay 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
126 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01859663
Sponsor's protocol ID
IRB 1303003665
Status last verified
Feb 2024
First submitted
17 May 2013
Last updated
9 Feb 2024
Results posted
No
Data monitoring committee
No

Publications

  • Evans AT, Rehani E, Smith B, Hong MD, Lewin Z, Hiroshige K, Spandorfer SD, Hajirasouliha I, Lujan ME, Hoeger KM. Diagnosis of Polycystic Ovary Syndrome With Predictive Modeling of Select Clinical Features. O G Open. 2026 Mar 19;3(2):e161. doi: 10.1097/og9.0000000000000161. eCollection 2026 Apr.

    PubMed 41868592
  • Lin AW, Dollahite JS, Sobal J, Lujan ME. Health-related knowledge, beliefs and self-efficacy in women with polycystic ovary syndrome. Hum Reprod. 2018 Jan 1;33(1):91-100. doi: 10.1093/humrep/dex351.

    PubMed 29182737

Questions about this trial

What is this clinical trial studying?

An observational study of Polycystic Ovary Syndrome and Dietary Habits, run by Cornell University at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in diet between women with and without PCOS (time frame: 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01859663, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in